Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults
- Status
- COMPLETED
- Phase
- PHASE3
The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC)
- Status
- COMPLETED
- Phase
- PHASE2